Kivi Pharmakon Private Limited
About Kivi Pharmakon Private Limited
Data last updated:
Kivi Pharmakon Private Limited is a private limited company based in Bhubaneswar, Odisha, India. It was incorporated on 24 July 2023.
The company is registered with the Registrar of Companies (ROC), Cuttack, under CIN U47721OD2023PTC043265.
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Avik Mukherjee (Managing Director) and Rupala Mukherjee.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Bhubaneswar, Odisha.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.61 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹3.11 Lakh (net margin 1.2%) and EBITDA of ₹5.35 Lakh (EBITDA margin 2%).
The company has about 16 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹77.79 Lakh on record.
Company details
Contact details
Kivi Pharmakon Private Limited's registered office is in Bhubaneswar, Odisha.
- Registered AddressHouse Number 2/2259, Rudrapur Pahal, Bhubaneswar, Odisha, India – 752101
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Kivi Pharmakon is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Kivi Pharmakon Private Limited, buy the company report.
Financials of Kivi Pharmakon Private Limited
FY 2025 filings availableKivi Pharmakon Private Limited reported revenue of ₹2.61 Cr (up 173% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 173% in the latest year. EBITDA rose 238% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ₹5.35 Lakh | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ₹3.11 Lakh | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 2% | |
| Net Profit Margin | 1.2% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Kivi Pharmakon Private Limited, buy the company report.
Board of directors of Kivi Pharmakon Private Limited
Kivi Pharmakon has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rupala Mukherjee | Director | 24 Jul 2023 | 3 Years 3 Months | Current |
| Avik Mukherjee | Managing Director | 24 Jul 2023 | 3 Years 3 Months | Current |
Peer comparison
Kivi Pharmakon Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Valunova Lifesciences Private Limited | ₹2.63 Cr (FY 2025) | 7.0% | Ahmedabad, Gujarat, India | |||
| CKG Life Sciences Private Limited | ₹2.62 Cr (FY 2018) | -33.0% | Delhi, India | |||
| Alson Pharma Private Limited | ₹2.62 Cr (FY 2025) | 30.0% | Kota, Rajasthan, India | |||
| Kivi Pharmakon Private Limitedthis company | ₹2.61 Cr (FY 2025) | ₹3.11 Lakh | 1.2% | 173.0% | Bhubaneswar, Odisha, India | |
| Vernoxy Pharma Private Limited | ₹2.61 Cr (FY 2024) | 22.0% | Valsad, Gujarat, India |
To see the full peer comparison of Kivi Pharmakon Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 22 Dec 2025 | 101212977 | Others | ₹60 Lakh | Open | |
| 04 Aug 2025 | 101139226 | Canara Bank | ₹10 Lakh | Open | |
| 23 May 2024 | 100936117 | Hdfc Bank Limited | ₹7.79 Lakh | Open |
Total charge records: 3 View all charges
Legal cases
No court or tribunal cases involving Kivi Pharmakon Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Kivi Pharmakon Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Kivi Pharmakon Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Kivi Pharmakon Private Limited has 2 board changes on record since 2023: 2 appointments. The latest: Avik Mukherjee was appointed as Managing Director on 24 Jul 2023.
Frequently asked questions
Kivi Pharmakon is an active private limited company based in Bhubaneswar, Odisha, India. It was incorporated on 24 July 2023 (3+ years old) and is registered under CIN U47721OD2023PTC043265.
Kivi Pharmakon has 2 current directors:
- Avik Mukherjee - Managing Director
- Rupala Mukherjee - Director
The latest financial statements of Kivi Pharmakon on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2024 are in the company report.
The CIN (Corporate Identification Number) of Kivi Pharmakon is U47721OD2023PTC043265. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Kivi Pharmakon was incorporated on 24 July 2023, making it 3+ years old. It is registered with the Registrar of Companies, Cuttack.
The peers of Kivi Pharmakon by revenue are Valunova Lifesciences Private Limited, CKG Life Sciences Private Limited, Alson Pharma Private Limited, Vernoxy Pharma Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Avik Mukherjee was appointed as Managing Director on 24 Jul 2023. Rupala Mukherjee was appointed as Director on 24 Jul 2023.
The registered office of Kivi Pharmakon is at House Number 22259, Rudrapur Pahal, Bhubaneswar, Odisha, India – 752101.
Kivi Pharmakon has open charges of ₹77.79 Lakh and no satisfied charges on record as per latest MCA filings.
Kivi Pharmakon can be reached at its registered office: House Number 22259, Rudrapur Pahal, Bhubaneswar, Odisha, India – 752101.
Kivi Pharmakon is registered under the jurisdiction of the Registrar of Companies (ROC), Cuttack.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
